(Q33848695)

29 July 2017

1 reference

title

Advanced glycation end products: a Nephrologist's perspective (English)

1 reference

29 July 2017

Raj DS

1

1 reference

29 July 2017

Choudhury D

series ordinal

2

1 reference

29 July 2017

Welbourne TC

series ordinal

3

1 reference

29 July 2017

Levi M

series ordinal

4

1 reference

29 July 2017

1 March 2000

1 reference

American Journal of Kidney Diseases

29 July 2017

1 reference

29 July 2017

35

1 reference

29 July 2017

365-380

1 reference

29 July 2017

3

1 reference

Lilly Lecture 1993. Glycation and diabetic complications

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Hemoglobin-AGE: a circulating marker of advanced glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Renal catabolism of advanced glycation end products: the fate of pentosidine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Protein glycation in the kidney: role in diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycosylation end products in diabetic renal and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Glucose homeostasis and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Radioreceptor Assay for Advanced Glycosylation End Products

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Standardizing the immunological measurement of advanced glycation endproducts using normal human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Serum advanced glycosylation end products: a new class of uremic toxins?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Ageing promotes the increase of early glycation Amadori product as assessed by epsilon-N-(2-furoylmethyl)-L-lysine (furosine) levels in rodent skin collagen. The relationship to dietary restriction and glycoxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Glycation and oxidation: a role in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Increased aggregation of human platelets produced by advanced glycation end products in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Amadori glucose adducts modulate mesangial cell growth and collagen gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycation end products, oxidant stress and vascular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Tobacco smoke is a source of toxic reactive glycation products

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Metabolism of fructose-3-phosphate in the diabetic rat lens

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

3-Deoxyfructose concentrations are increased in human plasma and urine in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Diabetic nephropathy: strategies in prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Early glycosylation products induce glomerular hyperfiltration in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Production of pseudodiabetic renal glomerular changes in mice after repeated injections of glucosylated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Early immunopathologic events in experimental diabetic nephropathy: a study in db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Reinvestigation of lipid peroxidation of linolenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Formation of methylglyoxal-modified proteins in vitro and in vivo and their involvement in AGE-related processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: evidence for increased oxidative stress in uremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Accumulation of advanced glycation endproducts in the rat nephron: link with circulating AGEs during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Effect of cross-linking on matrix permeability. A model for AGE-modified basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Glycation of albumin, not glomerular basement membrane, alters permeability in an in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Interactions of LDL and modified LDL with mesangial cells and matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Beta 2-microglobulin modified with the AGE products of the Maillard reaction in dialysis-related amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycation end products of the Maillard reaction and their relation to aging

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Aminoguanidine prolongs survival in azotemic-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

In vitro formation of advanced glycation end products in peritoneal dialysis fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

Effects of kidney or kidney-pancreas transplantation on plasma pentosidine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970189-2

7 January 2021

10.1016/S0272-6386(00)70189-2

Identifiers

DOI

1 reference

release_sdfw32vgcrb2lp5gitx7hr64mm

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sdfw32vgcrb2lp5gitx7hr64mm

24 November 2022

mapped directly with Wikidata item

1 reference